The compatibility of pharmaceutical packaging is a breakthrough in the industry
According to relevant statistics, in recent years, China's pharmaceutical packaging industry has maintained an average annual growth rate of more than 10%, and its GDP has accounted for more than 10% of the national packaging industry's GDP, higher than the pharmaceutical industry's share of the country's total industrial output. .
It is understood that after the drug is packed in packaging materials, migration, infiltration, corrosion, adsorption, and the like may occur, which in turn affects the quality of the drug. Therefore, research on the compatibility of packaging materials is still the key.
The compatibility experiment is to investigate whether these phenomena occur between the drug package and the drug, and the purpose is to ensure the safety, effectiveness and uniformity of the drug. The research on this aspect of domestic pharmaceutical companies is even more inadequate. Therefore, the compatibility of pharmaceutical packaging materials will be the focus of the work of the regulatory authorities in the future.
Relevant experts pointed out that in the next five years, China's pharmaceutical packaging industry will focus on the development of new, environmentally friendly, degradable and easy-to-use pharmaceutical packaging materials and containers. According to the “2010-2013 China Pharmaceutical Packaging Market Analysis and Investment Strategy Research Report” released by Shangpu Consulting, due to the rapid development of the pharmaceutical industry, the capacity expansion of China's pharmaceutical packaging industry has been basically completed. However, a new round of competition is about to begin, and the compatibility of pharmaceutical packaging is the first priority that China's pharmaceutical packaging factories should break through.
The domestic pharmaceutical packaging industry is still in a large but not strong stage, and it is necessary to strengthen the research and development of new materials and new processes, especially the problem of material compatibility needs to be solved. The “Twelfth Five-Year Plan” of the pharmaceutical packaging industry will reintegrate many unregulated content into the scope of supervision, which makes it necessary for pharmaceutical companies to pay more attention to the compatibility of packaging materials, which is a rare opportunity for pharmaceutical packaging enterprises. .
Development trend of medicine packaging materials